United StatesBuprenorphine Sublingual Tablets (C-III), 2 mg, 30 tablets (3x10), Rx only, distributed by American Health Packaging, Columbus, Ohio, Carton NDC 60687-481-21 (individual dose NDC 60687-481-11), Lot #1030023, Exp 06/30/2027, is affected. It was recalled due to a labeling mix-up.
What's being recalled
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Recalling firm: American Health Packaging, Columbus, OH, United States.
How to identify it
Lot # 1030023, Exp Date: 06/30/2027.
The hazard
Labeling: Label Mix-up
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)